Ken Research Logo

Global Veterinary Molecular Diagnostics Market Outlook to 2030

Region:Global

Author(s):Shivani Mehra

Product Code:KROD11149

Published On

December 2024

Total pages

91

About the Report

Global Veterinary Molecular Diagnostics Market Overview

  • The global veterinary molecular diagnostics market is valued at approximately USD 323.63 million, based on a five-year historical analysis. This valuation is driven by the increasing prevalence of zoonotic diseases, advancements in molecular diagnostic technologies, and a growing emphasis on animal health and welfare. The demand for accurate and rapid diagnostic tools in veterinary medicine has surged, leading to significant market growth.

market overviews

  • North America stands as the dominant region in the veterinary molecular diagnostics market. This dominance is attributed to the high adoption rate of companion animals, substantial investments in animal healthcare, and the presence of major market players. Additionally, stringent regulatory frameworks and a well-established veterinary infrastructure contribute to the region's leading position in the market.
  • Governments globally are establishing animal health surveillance programs to monitor and control the spread of infectious diseases in animals, with a focus on preventing zoonotic diseases that may affect humans. The U.S. Department of Agriculture (USDA), for instance, has expanded its National Animal Health Monitoring System (NAHMS), which collects and analyzes data on livestock health across the country. These programs strengthen early detection and intervention capabilities, which help maintain public health and support the agricultural economy by minimizing losses due to disease.

Global Veterinary Molecular Diagnostics Market Segmentation

By Product Type: The veterinary molecular diagnostics market is segmented by product type into instruments, kits and reagents, and software and services. Kits and reagents hold a dominant market share due to their widespread use in diagnostic procedures and the continuous development of advanced reagents that enhance test accuracy and efficiency.

market overviews

By Region: The market is divided into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. North America leads the market, driven by factors such as advanced veterinary healthcare infrastructure, high pet ownership rates, and significant investments in research and development.

market overviews

Global Veterinary Molecular Diagnostics Market Competitive Landscape

The veterinary molecular diagnostics market is characterized by the presence of several key players who contribute to its growth and development. The table below provides an overview of five major companies in the market

Company Name

Establishment Year

Headquarters Location

Product Portfolio

Annual Revenue (USD Billion)

Number of Employees

Global Presence

Recent Developments

Strategic Initiatives

IDEXX Laboratories, Inc.

1983

Westbrook, USA

Thermo Fisher Scientific Inc.

1956

Waltham, USA

Zoetis Inc.

1952

Parsippany, USA

QIAGEN N.V.

1984

Venlo, Netherlands

bioMrieux SA

1963

Marcy-l'toile, France

Global Veterinary Molecular Diagnostics Market Analysis

Market Growth Drivers

  • Rising Incidence of Zoonotic Diseases: The increasing occurrence of zoonotic diseases has heightened the demand for advanced veterinary diagnostics. According to the World Health Organization, of emerging infectious diseases are zoonotic in origin, underscoring the need for robust diagnostic capabilities to monitor and control these diseases.
  • Technological Advancements in Molecular Diagnostics: Technological innovations, particularly in molecular diagnostics, have revolutionized veterinary medicine. The adoption of Polymerase Chain Reaction (PCR) and Next-Generation Sequencing (NGS) technologies has enabled rapid and accurate detection of pathogens, facilitating timely interventions. These advancements have improved disease surveillance and management in the veterinary sector.
  • Increasing Pet Ownership and Expenditure: The rise in pet ownership has led to greater spending on animal health services. Data from the World Bank indicates that higher disposable incomes have contributed to increased expenditure on pet care, including diagnostics. This trend reflects a growing awareness of animal health and well-being among pet owners.

Market Challenges:

  • High Cost of Diagnostic Instruments: The substantial investment required for advanced diagnostic equipment poses a significant challenge, especially for smaller veterinary practices and clinics. The World Bank highlights that high costs limit accessibility to essential diagnostic services, especially in developing regions, which affects the quality and reach of animal healthcare. For example, acquiring molecular diagnostic tools and maintaining them in rural areas can be financially unfeasible without government or institutional support.
  • Lack of Skilled Veterinary Professionals: The shortage of trained veterinary professionals, particularly in specialized diagnostic fields, limits the effective deployment of advanced diagnostic technologies. The World Health Organization (WHO) notes that the global shortage of skilled professionals constrains the delivery of quality veterinary care, particularly in areas where the demand for diagnostics is growing. This skills gap creates challenges in adopting advanced diagnostic tools in many regions.

Global Veterinary Molecular Diagnostics Market Future Outlook

Over the next five years, the global veterinary molecular diagnostics market is expected to experience significant growth. This expansion is driven by continuous advancements in diagnostic technologies, increasing awareness of animal health, and the rising prevalence of zoonotic diseases. Additionally, the integration of artificial intelligence and machine learning in diagnostic tools is anticipated to enhance the accuracy and efficiency of veterinary diagnostics, further propelling market growth.

Market Opportunities:

  • Emerging Markets in Developing Regions: Developing regions, particularly in Africa, Asia, and Latin America, are witnessing an increasing focus on animal health infrastructure. According to World Bank data, these regions are experiencing growing investments in veterinary diagnostics due to rising livestock production and concerns over zoonotic diseases. With large rural populations reliant on livestock for economic livelihood, there is a significant demand for accessible, affordable diagnostic services to improve animal health and productivity.
  • Integration of AI and Machine Learning in Diagnostics: Artificial Intelligence (AI) and Machine Learning (ML) are making strides in improving diagnostic accuracy and speed within veterinary medicine. The World Economic Forum notes that AI has transformed medical fields by enhancing data analysis, which aids in better diagnostic predictions and faster decision-making. This application in veterinary diagnostics can support veterinarians in early disease detection and personalized treatment plans.

Scope of the Report

By Product Type

Instruments
Kits and Reagents
Software and Services

By Technology

Polymerase Chain Reaction (PCR)
Microarray
DNA Sequencing
Others

By Application

Infectious Diseases
Genetic Disorders
Oncology
Others

By Animal Type

Companion Animals
Dogs
Cats
Horses
Others
Livestock Animals
Cattle
Swine
Poultry
Others

By Region

North America
Europe
Asia-Pacific
Latin America
Middle East & Africa

Products

Key Target Audience

  • Veterinary Hospitals and Clinics

  • Diagnostic Laboratories

  • Research Institutes

  • Pharmaceutical and Biotechnology Companies

  • Government and Regulatory Bodies (e.g., U.S. Department of Agriculture, European Medicines Agency)

  • Animal Health Organizations

  • Veterinary Equipment Manufacturers

  • Investment and Venture Capitalist Firms

Companies

Players Mention in the Report 

  • IDEXX Laboratories, Inc.

  • Thermo Fisher Scientific Inc.

  • Zoetis Inc.

  • QIAGEN N.V.

  • bioMrieux SA

  • Heska Corporation

  • Neogen Corporation

  • Virbac

  • Agfa-Gevaert Group

  • Veterinary Molecular Diagnostics, Inc.

  • Novacyt Group

  • Bionote, Inc.

  • Randox Laboratories Ltd.

  • Abaxis, Inc.

  • VCA Inc.

Table of Contents

01. Market Overview

Definition and Scope

Market Taxonomy

Market Growth Rate

Market Segmentation Overview

02. Market Size (USD Billion)

Historical Market Size

Year-On-Year Growth Analysis

Key Market Developments and Milestones

03. Market Analysis

Growth Drivers

Rising Incidence of Zoonotic Diseases

Technological Advancements in Molecular Diagnostics

Increasing Pet Ownership and Expenditure

Expansion of Livestock Industry

Market Challenges

High Cost of Diagnostic Instruments

Lack of Skilled Veterinary Professionals

Regulatory Hurdles

Opportunities

Emerging Markets in Developing Regions

Integration of AI and Machine Learning in Diagnostics

Development of Point-of-Care Testing Solutions

Trends

Adoption of PCR and Next-Generation Sequencing Technologies

Shift Towards Personalized Veterinary Medicine

Growth in Companion Animal Diagnostics

Government Regulations

Animal Health Surveillance Programs

Veterinary Diagnostic Device Approvals

International Trade Regulations Affecting Veterinary Products

SWOT Analysis

Stakeholder Ecosystem

Porters Five Forces Analysis

Competitive Landscape

04. Market Segmentation

By Product Type (Value %)

Instruments

Kits and Reagents

Software and Services

By Technology (Value %)

Polymerase Chain Reaction (PCR)

Microarray

DNA Sequencing

Others

By Application (Value %)

Infectious Diseases

Genetic Disorders

Oncology

Others

By Animal Type (Value %)

Companion Animals

Dogs

Cats

Horses

Others

Livestock Animals

Cattle

Swine

Poultry

Others

By Region (Value %)

North America

Europe

Asia-Pacific

Latin America

Middle East & Africa

05. Competitive Analysis

Detailed Profiles of Major Companies

IDEXX Laboratories, Inc.

Thermo Fisher Scientific Inc.

Zoetis Inc.

QIAGEN N.V.

bioMrieux SA

Heska Corporation

Neogen Corporation

Virbac

Agfa-Gevaert Group

Veterinary Molecular Diagnostics, Inc.

Novacyt Group

Bionote, Inc.

Randox Laboratories Ltd.

Abaxis, Inc.

VCA Inc.

Cross Comparison Parameters

Number of Employees

Headquarters Location

Year of Inception

Annual Revenue

Product Portfolio

Market Share

Recent Developments

Strategic Initiatives

Market Share Analysis

Strategic Initiatives

Mergers and Acquisitions

Investment Analysis

Venture Capital Funding

Government Grants

Private Equity Investments

06. Regulatory Framework

Veterinary Diagnostic Device Regulations

Compliance Requirements

Certification Processes

07. Future Market Size (USD Billion)

Future Market Size Projections

Key Factors Driving Future Market Growth

08. Future Market Segmentation

By Product Type (Value %)

By Technology (Value %)

By Application (Value %)

By Animal Type (Value %)

By Region (Value %)

09. Analysts Recommendations

Total Addressable Market (TAM), Serviceable Available Market (SAM), and Serviceable Obtainable Market (SOM) Analysis

Customer Cohort Analysis

Marketing Initiatives

White Space Opportunity Analysis

Disclaimer Contact Us

Research Methodology

Step 1: Identification of Key Variables

The initial phase involves constructing an ecosystem map encompassing all major stakeholders within the global veterinary molecular diagnostics market. This step is underpinned by extensive desk research, utilizing a combination of secondary and proprietary databases to gather comprehensive industry-level information. The primary objective is to identify and define the critical variables that influence market dynamics.

Step 2: Market Analysis and Construction

In this phase, we compile and analyze historical data pertaining to the global veterinary molecular diagnostics market. This includes assessing market penetration, the ratio of marketplaces to service providers, and the resultant revenue generation. Furthermore, an evaluation of service quality statistics is conducted to ensure the reliability and accuracy of the revenue estimates.

Step 3: Hypothesis Validation and Expert Consultation

Market hypotheses are developed and subsequently validated through computer-assisted telephone interviews (CATIs) with industry experts representing a diverse array of companies. These consultations provide valuable operational and financial insights directly from industry practitioners, which are instrumental in refining and corroborating the market data.

Step 4: Research Synthesis and Final Output

The final phase involves direct engagement with multiple diagnostic equipment manufacturers to acquire detailed insights into product segments, sales performance, consumer preferences, and other pertinent factors. This interaction serves to verify and complement the statistics derived from the bottom-up approach, thereby ensuring a comprehensive, accurate, and validated analysis of the global veterinary molecular diagnostics market.

Frequently Asked Questions

01. How big is the global veterinary molecular diagnostics market?

The global veterinary molecular diagnostics market is valued at approximately USD 323.63 million, based on a five-year historical analysis.

02. What are the challenges in the global veterinary molecular diagnostics market?

Challenges include the high cost of diagnostic instruments, a lack of skilled veterinary professionals, and regulatory hurdles that can impede the swift adoption of new technologies.

03. Who are the major players in the global veterinary molecular diagnostics market?

Key players in the market include IDEXX Laboratories, Inc., Thermo Fisher Scientific Inc., Zoetis Inc., QIAGEN N.V., and bioMrieux SA. These companies dominate due to their extensive product portfolios, global presence, and continuous investment in research and development.

04. What are the growth drivers of the global veterinary molecular diagnostics market?

The market is propelled by factors such as the rising incidence of zoonotic diseases, technological advancements in molecular diagnostics, increasing pet ownership, and the expansion of the livestock industry.

Why Buy From Us?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

Our Reach Is Unmatched
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022